Skip to main content
PMC home page
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1996 Nov;3(6):635–639. doi: 10.1128/cdli.3.6.635-639.1996

Detection of Toxoplasma gondii tachyzoites and bradyzoites in blood, urine, and brains of infected mice.

T D Nguyen 1, M de Kesel 1, G Bigaignon 1, P Hoet 1, G Pazzaglia 1, M Lammens 1, M Delmee 1
PMCID: PMC170423  PMID: 8914751

Abstract

Different techniques for identifying Toxoplasma gondii were compared. PCR was used to amplify part of the major surface antigen P30 gene of T. gondii. Amplified-DNA detection with the DNA enzyme immunoassay (PCR-DEIA) was more sensitive than ethidium bromide staining after agarose gel electrophoresis and as sensitive as nested PCR. PCR-DEIA, using common enzyme-linked immunosorbent assay (ELISA) methods, avoids agarose gel electrophoresis for the identification of amplified products. T. gondii can also be detected with equal sensitivity in infected fibroblasts, but only after at least 8 days of cell culture. PCR-DEIA is thus recommended because of its sensitivity and convenience for detecting early parasitemia in the surveillance of toxoplasmosis among pregnant women and immunocompromised hosts. The courses of infection in mice infected with two strains of T. gondii were compared. Tachyzoites of the virulent strain T. gondii RH, killing the host in 4 days, were identified in urine specimens and blood samples of mice 24 to 94 h after inoculation but not in brains, but no antibodies were detected. After intraperitoneal inoculation with cysts of the low-level virulence Beverley strain of T. gondii, parasites were identified in blood samples 4 days later and up to 17 days (but not in urine specimens) and in the brain from day 6 through day 525. By ELISA, high antibody titers were found from day 11 to day 525, with parasitemia preceding the appearance of antibodies. The usefulness of PCR-DEIA tests in conjunction with the search for circulating antibodies for the early diagnosis of toxoplasmosis in humans is discussed.

Full Text

The Full Text of this article is available as a PDF (285.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ades A. E. Methods for estimating the incidence of primary infection in pregnancy: a reappraisal of toxoplasmosis and cytomegalovirus data. Epidemiol Infect. 1992 Apr;108(2):367–375. doi: 10.1017/s0950268800049839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bignold L. P. Preparative techniques influencing sedimentation of erythrocytes through the Hypaque-Ficoll medium used in the one-step technique for separation of human polymorphonuclear leukocytes from whole blood. J Immunol Methods. 1988 Jan 21;106(1):147–149. doi: 10.1016/0022-1759(88)90282-7. [DOI] [PubMed] [Google Scholar]
  3. Burg J. L., Perelman D., Kasper L. H., Ware P. L., Boothroyd J. C. Molecular analysis of the gene encoding the major surface antigen of Toxoplasma gondii. J Immunol. 1988 Nov 15;141(10):3584–3591. [PubMed] [Google Scholar]
  4. Carter A. O., Frank J. W. Congenital toxoplasmosis: epidemiologic features and control. CMAJ. 1986 Sep 15;135(6):618–623. [PMC free article] [PubMed] [Google Scholar]
  5. Chardès T., Bourguin I., Mevelec M. N., Dubremetz J. F., Bout D. Antibody responses to Toxoplasma gondii in sera, intestinal secretions, and milk from orally infected mice and characterization of target antigens. Infect Immun. 1990 May;58(5):1240–1246. doi: 10.1128/iai.58.5.1240-1246.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Decoster A., Darcy F., Caron A., Capron A. IgA antibodies against P30 as markers of congenital and acute toxoplasmosis. Lancet. 1988 Nov 12;2(8620):1104–1107. doi: 10.1016/s0140-6736(88)90523-5. [DOI] [PubMed] [Google Scholar]
  7. Derouin F., Mazeron M. C., Garin Y. J. Comparative study of tissue culture and mouse inoculation methods for demonstration of Toxoplasma gondii. J Clin Microbiol. 1987 Sep;25(9):1597–1600. doi: 10.1128/jcm.25.9.1597-1600.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Desmonts G., Naot Y., Remington J. S. Immunoglobulin M-immunosorbent agglutination assay for diagnosis of infectious diseases: diagnosis of acute congenital and acquired Toxoplasma infections. J Clin Microbiol. 1981 Nov;14(5):486–491. doi: 10.1128/jcm.14.5.486-491.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Filice G. A., Hitt J. A., Mitchell C. D., Blackstad M., Sorensen S. W. Diagnosis of Toxoplasma parasitemia in patients with AIDS by gene detection after amplification with polymerase chain reaction. J Clin Microbiol. 1993 Sep;31(9):2327–2331. doi: 10.1128/jcm.31.9.2327-2331.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Guzzini F., Ceppi M., Cozzi C., Giussani R., Tomasi A. Leucemia plasmacellulare esordita con versamento pleurico. Minerva Med. 1989 Feb;80(2):177–180. [PubMed] [Google Scholar]
  11. Ho-Yen D. O., Joss A. W., Balfour A. H., Smyth E. T., Baird D., Chatterton J. M. Use of the polymerase chain reaction to detect Toxoplasma gondii in human blood samples. J Clin Pathol. 1992 Oct;45(10):910–913. doi: 10.1136/jcp.45.10.910. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hohlfeld P., Daffos F., Costa J. M., Thulliez P., Forestier F., Vidaud M. Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid. N Engl J Med. 1994 Sep 15;331(11):695–699. doi: 10.1056/NEJM199409153311102. [DOI] [PubMed] [Google Scholar]
  13. Holliman R., Johnson J., Savva D., Cary N., Wreghitt T. Diagnosis of toxoplasma infection in cardiac transplant recipients using the polymerase chain reaction. J Clin Pathol. 1992 Oct;45(10):931–932. doi: 10.1136/jcp.45.10.931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Holodniy M., Kim S., Katzenstein D., Konrad M., Groves E., Merigan T. C. Inhibition of human immunodeficiency virus gene amplification by heparin. J Clin Microbiol. 1991 Apr;29(4):676–679. doi: 10.1128/jcm.29.4.676-679.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hughes H. P., Hudson L., Fleck D. G. In vitro culture of Toxoplasma gondii in primary and established cell lines. Int J Parasitol. 1986 Aug;16(4):317–322. doi: 10.1016/0020-7519(86)90109-8. [DOI] [PubMed] [Google Scholar]
  16. Huskinson J., Stepick-Biek P., Remington J. S. Detection of antigens in urine during acute toxoplasmosis. J Clin Microbiol. 1989 May;27(5):1099–1101. doi: 10.1128/jcm.27.5.1099-1101.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Joss A. W., Chatterton J. M., Evans R., Ho-Yen D. O. Toxoplasma polymerase chain reaction on experimental blood samples. J Med Microbiol. 1993 Jan;38(1):38–43. doi: 10.1099/00222615-38-1-38. [DOI] [PubMed] [Google Scholar]
  18. Lappalainen M., Koskela P., Hedman K., Teramo K., Ammälä P., Hiilesmaa V., Koskiniemi M. Incidence of primary toxoplasma infections during pregnancy in southern Finland: a prospective cohort study. Scand J Infect Dis. 1992;24(1):97–104. doi: 10.3109/00365549209048407. [DOI] [PubMed] [Google Scholar]
  19. Li H., Cui X., Arnheim N. Direct electrophoretic detection of the allelic state of single DNA molecules in human sperm by using the polymerase chain reaction. Proc Natl Acad Sci U S A. 1990 Jun;87(12):4580–4584. doi: 10.1073/pnas.87.12.4580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Mantero G., Zonaro A., Albertini A., Bertolo P., Primi D. DNA enzyme immunoassay: general method for detecting products of polymerase chain reaction. Clin Chem. 1991 Mar;37(3):422–429. [PubMed] [Google Scholar]
  21. Papoz L., Simondon F., Saurin W., Sarmini H. A simple model relevant to toxoplasmosis applied to epidemiologic results in France. Am J Epidemiol. 1986 Jan;123(1):154–161. doi: 10.1093/oxfordjournals.aje.a114210. [DOI] [PubMed] [Google Scholar]
  22. Savva D., Morris J. C., Johnson J. D., Holliman R. E. Polymerase chain reaction for detection of Toxoplasma gondii. J Med Microbiol. 1990 May;32(1):25–31. doi: 10.1099/00222615-32-1-25. [DOI] [PubMed] [Google Scholar]
  23. Schoondermark-Van de Ven E., Melchers W., Camps W., Eskes T., Meuwissen J., Galama J. Effectiveness of spiramycin for treatment of congenital Toxoplasma gondii infection in rhesus monkeys. Antimicrob Agents Chemother. 1994 Sep;38(9):1930–1936. doi: 10.1128/aac.38.9.1930. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Schoondermark-Van de Ven E., Melchers W., Galama J., Camps W., Eskes T., Meuwissen J. Congenital toxoplasmosis: an experimental study in rhesus monkeys for transmission and prenatal diagnosis. Exp Parasitol. 1993 Sep;77(2):200–211. doi: 10.1006/expr.1993.1077. [DOI] [PubMed] [Google Scholar]
  25. Tomasi J. P., Barka N., Stadtsbaeder S. Serodiagnosis of human G and M immunoglobulins to Toxoplasma gondii by ELISA using whole tachyzoites as antigens: a comparative study with the indirect haemagglutination (IHA) and immunofluorescence (IFA) tests. Med Microbiol Immunol. 1986;175(4):261–269. doi: 10.1007/BF02123734. [DOI] [PubMed] [Google Scholar]
  26. van Loon A. M., van der Logt J. T., Heessen F. W., van der Veen J. Enzyme-linked immunosorbent assay that uses labeled antigen for detection of immunoglobulin M and A antibodies in toxoplasmosis: comparison with indirect immunofluorescence and double-sandwich enzyme-linked immunosorbent assay. J Clin Microbiol. 1983 Jun;17(6):997–1004. doi: 10.1128/jcm.17.6.997-1004.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. van de Ven E., Melchers W., Galama J., Camps W., Meuwissen J. Identification of Toxoplasma gondii infections by BI gene amplification. J Clin Microbiol. 1991 Oct;29(10):2120–2124. doi: 10.1128/jcm.29.10.2120-2124.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES